Profile

James B. Caress, M.D.Wake Forest Baptist Health

Doctor Rating

4.6 out of 5

142 Ratings
10 Comments
 

James B. Caress, M.D.

Professor,

Clinical Interests

Myasthenia Gravis, ALS, Muscle Diseases, Muscle Cramps

Contact Information

Request An Appointment

New Patient Appointments: 336-716-WAKE
Returning Patient Appointments: 336-716-4101
Department: 336-716-7668

Insurance Accepted »

Education & Training

  • B.A., Colgate University, 1986
  • M.D., George Washington University School of Medicine, 1990
  • Internship, Internal Medicine, George Washington U Hosp, 1991
  • Residency, Neurology, Duke University Medical Center, 1994
  • Fellowship, Brigham & Women's Hosp, 1996

Board Certifications

  • American Board of Psychiatry and Neurology, Clinical Neurophysiology
  • American Board of Psychiatry and Neurology, Neurology
  • American Board of Psychiatry and Neurology, Neuromuscular Medicine

Memberships

  • American Academy of Neurology

NPI Number

  • 1184600264
James B. Caress, M.D.

Doctor Rating

4.6 out of 5

142 Ratings
10 Comments
 

James B. Caress, M.D.

Professor, Neurology

Research Interests

Muscle, Skeletal; Immunoglobulins, Intravenous; Amyotrophic Lateral Sclerosis; Peripheral Nerves; Stroke
More »

Contact Information

Request An Appointment

Academic: 336-716-2309 | Department: 336-716-7668

Recent Publications

Natural history of muscle cramps in amyotrophic lateral sclerosis. Caress JB, Ciarlone SL, Sullivan EA, Griffin LP, Cartwright MS.. Muscle Nerve. 2016;53(4):513-517.

Juvenile muscular atrophy of the distal upper extremities associated with X-linked periventricular heterotopia with features of Ehlers-Danlos syndrome. Hommel AL, Jewett T, Mortenson M, Caress JB.. Muscle Nerve. 2016;54(4):794-797.

Clinical-genetic associations in the Prospective Huntington at Risk Observational Study (PHAROS): implications for clinical trials. Biglan KM, Shoulson I, Kieburtz K, Oakes D, Kayson E, Shinaman MA, Zhao H, Romer M, Young A, Hersch S, Penney J, Marder K, Paulsen J, Quaid K, Siemers E, Tanner C, Mallonee W, Suter G, Dubinsky R, Gray C, Nance M, Bundlie S, Radtke D,.. JAMA Neurol. 2016;73(1):102-110.

A retrospective study of ultrasound guidance for diagnostic lumbar punctures. Lovin BD, Griffin LP, Walker FO, Baute V, Caress JB, Cartwright MS.. J Sci Med. 2016;2(1):25-30.

Defining SOD1 ALS natural history to guide therapeutic clinical trial design. Bali T, Self W, Liu J, Siddique T, Wang LH, Bird TD, Ratti E, Atassi N, Boylan KB, Glass JD, Maragakis NJ, Caress JB, McCluskey LF, Appel SH, Wymer JP, Gibson S, Zinman L, Mozaffar T, Callaghan B, McVey AL, Jockel-Balsarotti J, Allred P, Fisher ER,.. J Neurol Neurosurg Psychiatry. 2016;():.

A randomized trial of diagnostic ultrasound to improve outcomes in focal neuropathies. Cartwright MS, Griffin LP, Dowlen H, Bargoil JM, Caress JB, Li ZJ, Defranzo AJ Jr, Wiesler ER, Tuohy CJ, Balakrishnan N, Molnar JA, Baute V, Koman LA, Poehling GG, Walker FO.. Muscle Nerve. 2015;52(5):746-753.

Electrical impedance myography correlates with standard measures of ALS severity. Rutkove SB, Caress JB, Cartwright MS, Burns TM, Warder J, David WS, Goyal N, Maragakis NJ, Benatar M, Sharma KR, Narayanaswami P, Raynor EM, Watson ML, Shefner JM.. Muscle Nerve. 2014;49(3):441-443.

Safety, pharmacokinetic, and functional effects of the nogo-a monoclonal antibody in amyotrophic lateral sclerosis: a randomized, first-in-human clinical trial. Meininger V, Pradat PF, Corse A, Al-Sarraj S, Rix Brooks B, Caress JB, Cudkowicz M, Kolb SJ, Lange D, Leigh PN, Meyer T, Milleri S, Morrison KE, Orrell RW, Peters G, Rothstein JD, Shefner J, Lavrov A, Williams N, Overend P, Price J, Bates S, Bullman J,.. PLoS One. 2014;9(5):e97803.

Systemic pharmacokinetics and cerebrospinal fluid uptake of intravenous ceftriaxone in patients with amyotrophic lateral sclerosis. Zhao Y, Cudkowicz ME, Shefner JM, Krivickas L, David WS, Vriesendorp F, Pestronk A, Caress JB, Katz J, Simpson E, Rosenfeld J, Pascuzzi R, Glass J, Rezania K, Harmatz JS, Schoenfeld D, Greenblatt DJ.. J Clin Pharmacol. 2014;54(10):1180-1187.

Design and initial results of a multi-phase randomized trial of ceftriaxone in amyotrophic lateral sclerosis. Berry JD, Shefner JM, Conwit R, Schoenfeld D, Keroack M, Felsenstein D, Krivickas L, David WS, Vriesendorp F, Pestronk A, Caress JB, Katz J, Simpson E, Rosenfeld J, Pascuzzi R, Glass J, Rezania K, Rothstein JD, Greenblatt DJ, Cudkowicz ME.. PLoS One. 2013;8(4):e61177.

Characterization of early pathogenesis in the SOD1G93A mouse model of ALS: part I, background and methods. Vinsant S, Mansfield C, Jimenez-Moreno R, Moore VDG, Yoshikawa M, Hampton TG, Prevette D, Caress J, Oppenheim RW, Milligan C.. Brain Behav. 2013;3(4):335-350.

Characterization of early pathogenesis in the SOD1G93A mouse model of ALS: part II, results and discussion. Vinsant S, Mansfield C, Jimenez-Moreno R, Moore VDG, Yoshikawa M, Hampton TG, Prevette D, Caress J, Oppenheim RW, Milligan C.. Brain Behav. 2013;3(4):431-457.

Electrical impedance myography as a biomarker to assess ALS progression [abstract]. Rutkove S, Caress J, Cartwright M, Burns T, Warder J, David W, Goyal N, Maragakis N, Clawson L, Benatar M, Usher S, Sharma K, Guatam S, Narayanaswarmi P, Raynot E, Watson ML, Shefner J.. Neurology. 2012;78(Suppl 1):S25.006.

Administration of recombinant heat shock protein 70 delays peripheral muscle denervation in the SOD1G93A mouse model of amyotrophic lateral sclerosis. Gifondorwa DJ, Jimenz-Moreno R, Hayes CD, Rouhani H, Robinson MB, Strupe JL, Caress J, Milligan C.. Neurol Res Int. 2012;2012():170426.

Electrical impedance myography as a biomarker to assess ALS progression. Rutkove SB, Caress JB, Cartwright MS, Burns TM, Warder J, David WS, Goyal N, Maragakis NJ, Clawson L, Benatar M, Usher S, Sharma KR, Gautam S, Narayanaswami P, Raynor EM, Watson ML, Shefner JM.. Amyotroph Lateral Scler. 2012;13(5):439-445.

Multipoint incremental motor unit number estimation as an outcome measure in ALS. Shefner JM, Watson ML, Simionescu L, Caress JB, Burns TM, Maragakis NJ, Benatar M, David WS, Sharma KR, Rutkove SB.. Neurology. 2011;77(3):235-241.

Peripheral nerve and muscle ultrasound in amyotrophic lateral sclerosis. Cartwright MS, Walker FO, Griffin LP, Caress JB.. Muscle Nerve. 2011;44(3):346-351.

Bleeding and electromyography: the needle and the damage (not) done [editorial]. Caress JB.. Muscle Nerve. 2011;44(3):313-315.

Safety of intravenous immunoglobulin treatment. Caress JB, Kennedy BL, Eickman KD.. Expert Opin Drug Saf. 2010;9(6):971-979.

Increased intramuscular nerve branching and inhibition of programmed cell death of chick embryo motoneurons by immunoglobulins from patients with motoneuron disease. Hernandez S, Texido L, Caldero J, Ciutat D, Piedrafita L, Casanovas A, Caress J, Prevette D, Oppenheim RW, Milligan C, et al.. J Neuroimmunol. 2010;229(1-2):157-168.

What were you thinking?: individuals at risk for Huntington Disease talk about having children. Quaid KA, Swenson MM, Sims SL, Harrison JM, Moskowitz C, Stepanov N, Suter GW, Caress J, Walker F, Hunt V, et al.. J Genet Couns. 2010;19(6):606-617.

Case-control study of thromboembolic events associated with IV immunoglobulin. Caress JB, Hobson-Webb L, Passmore LV, Finkbiner AP, Cartwright MS.. J Neurol. 2009;256(3):339-342.

Diagnostic nerve ultrasound in Charcot-Marie-Tooth disease type 1B. Cartwright MS, Brown ME, Eulitt P, Walker FO, Lawson VH, Caress JB.. Muscle Nerve. 2009;40(1):98-102.

Identification of changes in muscle, neuromuscular junctions and spinal cord at early pre-symptomatic stages in the mutant SOD1 mouse model of ALS may provide novel insight for diagnosis and treatment development [abstract]. Yoshikawa M, Vinsant S, Mansfield CM, Gifondorwa DJ, Pace L, Messi LM [sic] [Messi ML], Caress J, Cartwright M, Delbono O, Oppenheim RW, Milligan CE, et al.. Soc Neurosci Abstr. 2009;2009(Neuroscience Meeting Planner):.

Cross-sectional area reference values for nerve ultrasonography. Cartwright MS, Passmore LV, Yoon J-S, Brown ME, Caress JB, Walker FO.. Muscle Nerve. 2008;37(5):566-571.

Revised statistical motor unit number estimation in the Celecoxib/ALS trial. Shefner JM, Cudkowicz ME, Zhang H, Schoenfeld D, Jillapalli D, Al-Lozi M, Caress JB, David W, Russell J, Graves M, et al.. Muscle Nerve. 2007;35(2):228-234.

Neurophysiology of nerve conduction studies. Caress JB, Esper GJ, Rutkove SB. In: Blum AS, Rutkove SB, eds. The clinical neurophysiology primer. Totowa (NJ): Humana Press;2007: 207-216.

Technical, physiological and anatomic considerations in nerve conduction studies. Caress JB. In: Blum AS, Rutkove SB, eds. The clinical neurophysiology primer. Totowa (NJ): Humana Press;2007: 217-227.

Exogenous delivery of heat shock protein 70 increases lifespan in a mouse model of amyotrophic lateral sclerosis. Gifondorwa DJ, Robinson MB, Hayes CD, Taylor AR, Prevette DM, Oppenheim RW, Caress J, Milligan CE.. J Neurosci. 2007;27(48):13173-80.

Trial of celecoxib in amyotrophic lateral sclerosis. Cudkowicz ME, Shefner JM, Schoenfeld DA, Zhang H, Andreasson KI, Donofrio P, Caress J, Ashburn C, Walker T, Dryman B, et al.. Ann Neurol. 2006;60(1):22-31.

At risk for Huntington disease: the PHAROS (Prospective Huntington At Risk Observational Study) Cohort enrolled. Shoulson I, Kieburtz K, Oakes D, Kayson E, Zhao H, Shinaman A, Romer M, Caress J, Walker F, Hunt V, et al.. Arch Neurol. 2006;63(7):991-996.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Professor, Neurology

Clinical Interests

Myasthenia Gravis, ALS, Muscle Diseases, Muscle Cramps
James B. Caress, M.D.

James B. Caress, M.D.

Professor, Neurology

Request An Appointment

Doctor Rating

4.6 out of 5

James B. Caress, M.D.142 Ratings
10 Comments


 

Doctor Ratings

The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Press Ganey Patient Satisfaction Survey

CP concern for questions/worries
4.6
CP efforts to include in decisions
4.6
CP explanations of prob/condition
4.6
CP spoke using clear language
4.7
Friendliness/courtesy of CP
4.7
Likelihood of recommending CP
4.7
Patients' confidence in CP
4.7
Time CP spent with patient
4.6
Wait time at clinic
4.3



Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.

8/15/2016

#9. He is the best.

7/26/2016

good

7/13/2016

I appreciate the wonderful care I have received so far with Doctor Caress and his team.

7/12/2016

He is the very best doctor ever.

6/26/2016

Dr. Caress and the whole clinic team are excellent, the level of care and compassion they show to the patients are immeasurable. We are treated like family from everyone at the clinic, and that is very much appreciated.

6/14/2016

The doctor seemed more concerned with his resident than helping me.

5/5/2016

All good.

4/19/2016

*Dr. James Caress is an asset to WFBH!

2/22/2016

Doctor was very kind and professional. He took the time to listen to me and provide answers to all my questions.

1/12/2016

Dr. Caress is very professional.

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
Comprehensive Cancer Centers National Designation is RenewedMagnet Hospital RecognitionConsumer Choice2015 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.

© Wake Forest Baptist Medical Center, Medical Center Boulevard, Winston-Salem, NC 27157. All Rights Reserved.